Procter & Gamble Health logo

Procter & Gamble Health MD, chairman, board of directors and AGM

NSE: PGHLBSE: 500126Pharmaceuticals & BiotechnologySmall Cap

Formerly Merck
Last close ₹5,015.00down ₹47.50 (0.94%)BSE ₹5,032.75

Share price at the NSE close on 23 Oct 2026. Previous close ₹5,062.50.

52-week range of traded prices to 23 Oct 2026
₹4,707.00Low, 6 Apr 2026₹6,975.00High, 15 Jul 2026
Market cap
₹8,325 Cr585th largest listed
P/E
23.3
P/B
15.9
Dividend yield
4.09%
ROE
67.2%
ROCE
84.2%
Debt to equity
0.00
Volume, NSE
18,32148.9% delivered

Procter & Gamble Health board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonSubramanian Madhavan
  • Managing directorMilind Thatte

7 directors3 independent2 executive2 non-executive

  • Subramanian Madhavan · ChairpersonIndependent · joined Nov 2021 · reappointed Nov 2021 · 53 months as independent · 5 listed boards · 5 as independent · 5 committee seats, 4 as chair
  • Milind Thatte · Managing directorExecutive · joined Apr 2018 · 1 listed board · 2 committee seats
  • Shashank SrowthyExecutive · joined Oct 2025 · 1 listed board · 1 committee seat
  • Aalok AgrawalNon-executive · joined Jun 2019 · 1 listed board
  • Seema SambasivanNon-executive · joined Apr 2023 · 1 listed board
  • Krishna SarmaIndependent · joined Apr 2025 · reappointed Apr 2025 · 18 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • Sharad TyagiIndependent · joined Apr 2025 · reappointed Apr 2025 · 18 months as independent · 2 listed boards · 2 as independent · 4 committee seats, 2 as chair

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

3 directors who left
  • Lokesh Chandak, left 30 Sep 2025: Others
  • Suresh Talwar, left 31 Mar 2025: Tenure Completion
  • Rani Ajit Jadhav, left 31 Mar 2025: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 6 Aug 20267 of 7 present3 independent · 71 days in between
    • 26 May 20267 of 7 present3 independent

  • Audit Committee

    Chair Krishna Sarma

    Subramanian Madhavan, Sharad Tyagi, Milind Thatte

    • 6 Aug 20264 of 4 present3 independent · 71 days in between
    • 26 May 20264 of 4 present3 independent

  • Nomination and remuneration committee

    Chair Sharad Tyagi

    Subramanian Madhavan, Aalok Agrawal

    • 18 Aug 20263 of 3 present2 independent · 83 days in between
    • 26 May 20263 of 3 present2 independent

  • Stakeholders Relationship Committee

    Chair Sharad Tyagi

    Milind Thatte, Shashank Srowthy

    • 26 May 20263 of 3 present1 independent

  • Risk Management Committee

    Chair Milind Thatte

    Subramanian Madhavan, Shashank Srowthy, Aalok Agrawal

    • 6 Aug 20264 of 4 present1 independent
    • 26 May 20264 of 4 present1 independent

  • Corporate Social Responsibility Committee

    Chair Milind Thatte

    Krishna Sarma, Shashank Srowthy

    • 8 Apr 20263 of 3 present1 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • Haribhakti & Co LLPPeer-review certificate valid to Jul 2027
1 earlier auditor
  • Kalyaniwalla & Mistry LLPNamed in the filing for the quarter to Dec 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Procter & Gamble Health AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Procter & Gamble Health dividend history

Annual general meeting, 3 Sep 2026

51,229 shareholders on the register on 27 Aug 2026; present: 1 promoter and 64 others; votes counted by CS Nrupang B. Dholakia / Dholakia & Associates LLP.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Balance Sheet as at March 31, 2026 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 66.35% · promoters 100.00% · institutions 76.14% · other public 0.13%

  2. To confirm payment of interim dividend and to declare Final Dividend for the Financial Year ended March 31, 2026.
    Ordinary
    99.93% for0.07% against

    Against: promoters 0.00% · institutions 0.31% · other public 0.06%

    Turnout: all 66.37% · promoters 100.00% · institutions 76.25% · other public 0.13%

  3. To appoint a director in place of Mr. Aalok Agrawal, Non-Executive Director (DIN 08468145), who retires by rotation and being eligible, offers himself for re- appointment.
    Ordinary
    99.52% for0.48% against

    Against: promoters 0.00% · institutions 2.18% · other public 4.03%

    Turnout: all 66.37% · promoters 100.00% · institutions 76.25% · other public 0.13%

  4. Ratification of remuneration payable to the Cost Auditor for the Financial Year 2026-27
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 66.37% · promoters 100.00% · institutions 76.25% · other public 0.13%

  5. Re-appointment of Mr. S. Madhavan (DIN 06451889) as Non-Executive Independent Director of the Company for a period of five years, effective November 15, 2026
    Special
    99.35% for0.65% against

    Against: promoters 0.00% · institutions 2.97% · other public 1.22%

    Turnout: all 66.37% · promoters 100.00% · institutions 76.25% · other public 0.13%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 16 Nov 2025, 1 resolution

51,591 shareholders on the register on 3 Oct 2025; votes counted by CS Nrupang B. Dholakia / Dholakia & Associates LLP.The company's voting result (opens in a new tab)

  1. Appointment of Mr. Shashank Srowthy (DIN 11317956) as an Executive Director of the Company for a period of five years, effective October 1, 2025, liable to retire by rotation.
    Ordinary
    99.60% for0.40% against

    Against: promoters 0.00% · institutions 1.66% · other public 2.51%

    Turnout: all 68.16% · promoters 100.00% · institutions 76.67% · other public 0.53%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 29 Aug 2025, 5 resolutions

51,525 shareholders on the register on 22 Aug 2025; present: 1 promoter and 76 others; votes counted by NRUPANG DHOLAKIA / DHOLAKIA & ASSOCIATES LLP.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Balance Sheet as at March 31, 2025 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereonMoreLess
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.03% · other public 0.20%

    Turnout: all 68.15% · promoters 100.00% · institutions 75.65% · other public 0.29%

  2. To confirm payment of interim dividend and to declare final dividend for the Financial Year ended March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.16%

    Turnout: all 68.17% · promoters 100.00% · institutions 75.73% · other public 0.29%

  3. To appoint a director in place of Ms. Seema Sambasivan, Non-Executive Director, who retires by rotation and being eligible, offers herself for re-appointment
    Ordinary
    99.62% for0.38% against

    Against: promoters 0.00% · institutions 1.57% · other public 1.64%

    Turnout: all 68.17% · promoters 100.00% · institutions 75.73% · other public 0.29%

  4. To appoint M/s. Dholakia & Associates, Practicing Company Secretaries, as secretarial auditors for a period of five years effective April 1, 2025
    Ordinary
    93.88% for6.12% against

    Against: promoters 0.00% · institutions 25.65% · other public 0.24%

    Turnout: all 68.17% · promoters 100.00% · institutions 75.73% · other public 0.29%

  5. Ratification of remuneration payable to the Cost Auditor for the Financial Year 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.20%

    Turnout: all 68.17% · promoters 100.00% · institutions 75.73% · other public 0.29%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 9 Apr 2025, 2 resolutions

55,590 shareholders on the register on 21 Feb 2025; votes counted by CS Nrupang B. Dholakia / Dholakia & Associates LLP.The company's voting result (opens in a new tab)

  1. Appointment of Mr. Sharad Tyagi (DIN 00371842) as a Non-Executive Independent Director of Company for a term of five years effective April 1, 2025, not liable to retire by rotation
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.73%

    Turnout: all 67.95% · promoters 100.00% · institutions 74.47% · other public 1.04%

  2. Appointment of Ms. Krishna Sarma (DIN 00016115) as a Non-Executive independent Director of the Company, for a term of five years effective April 1, 2025, not liable to retire by rotation
    Special
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.10% · other public 0.84%

    Turnout: all 67.95% · promoters 100.00% · institutions 74.47% · other public 1.04%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 5 Dec 2024, 4 resolutions

Present: 1 promoter and 48 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Balance Sheet as at June 30, 2024 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.28%

    Turnout: all 67.79% · promoters 100.00% · institutions 73.28% · other public 0.19%

  2. To confirm payment of interim dividend and to declare Final Dividend for the Financial Year ended June 30, 2024.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 67.79% · promoters 100.00% · institutions 73.28% · other public 0.19%

  3. To appoint a Director in place of Mr. Lokesh Chandak, Executive Director, who retires by rotation and being eligible, offers himself for re- appointment.
    Ordinary
    96.39% for3.61% against

    Against: promoters 0.00% · institutions 15.35% · other public 3.29%

    Turnout: all 67.79% · promoters 100.00% · institutions 73.28% · other public 0.19%

  4. Ratification of remuneration payable to the Cost Auditor for the Financial Year 2024-25.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.28%

    Turnout: all 67.79% · promoters 100.00% · institutions 73.28% · other public 0.19%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Nov 2023, 4 resolutions

Present: 1 promoter and 50 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Balance Sheet as at June 30, 2023 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.49% · promoters 100.00% · institutions 86.86% · other public 18.75%

  2. To confirm payment of interim dividend and to declare Final Dividend for the Financial Year ended June 30, 2023.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.49% · promoters 100.00% · institutions 86.86% · other public 18.75%

  3. To appoint a Director in place of Mr. Aalok Agrawal, Non-Executive Director {DIN 08468145), who retires by rotation and being eligible, offers himself for re- appointment.
    Ordinary
    96.86% for3.14% against

    Against: promoters 0.00% · institutions 0.17% · other public 29.21%

    Turnout: all 67.49% · promoters 100.00% · institutions 86.86% · other public 18.75%

  4. Ratification of remuneration payable to the Cost Auditor for the Financial Year 2023-24
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.49% · promoters 100.00% · institutions 86.86% · other public 18.75%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 10 May 2023, 2 resolutions

The company's voting result (opens in a new tab)

  1. Appointment of Mr. Lokesh Chandak (DIN 10083315) as an Executive Director of the Company for a period of five years, effective April 1, 2023, liable to retire by rotation.
    Ordinary
    98.60% for1.40% against

    Against: promoters 0.00% · institutions 7.73% · other public 1.24%

    Turnout: all 63.49% · promoters 100.00% · institutions 73.09% · other public 0.71%

  2. Appointment of Ms. Seema Sambasivan (DIN 10085866) as a Non-Executive Director of the Company, effective April 1, 2023, liable to retire by rotation.
    Ordinary
    98.41% for1.59% against

    Against: promoters 0.00% · institutions 8.80% · other public 1.30%

    Turnout: all 63.49% · promoters 100.00% · institutions 73.09% · other public 0.71%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 22 Mar 2023, 1 resolution

The company's voting result (opens in a new tab)

  1. RE-APPOINTMENT OF MR. MILIND THATTE (DIN 08092990) AS THEnMANAGING DIRECTOR OF THE COMPANY FOR A PERIOD OF FIVE YEARS EFFECTIVE APRIL 1, 2023
    Ordinary
    98.08% for1.92% against

    Against: promoters 0.00% · institutions 10.84% · other public 0.19%

    Turnout: all 63.75% · promoters 100.00% · institutions 72.97% · other public 1.97%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 3 Sep 2026, 4 fund houses so far (houses' deadline to file 15 Oct 2026)

  • To receive, consider and adopt the Audited Balance Sheet as at March 31, 2026 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereon.MoreLess
    4 for0 against
  • To confirm payment of interim dividend and to declare Final Dividend for the Financial Year ended March 31, 2026.
    4 for0 against
  • To appoint a director in place of Mr. Aalok Agrawal, Non-Executive Director (DIN 08468145), who retires by rotation and being eligible, offers himself for re- appointment.
    4 for0 against
  • Ratification of remuneration payable to the Cost Auditor for the Financial Year 2026-27
    4 for0 against
  • Re-appointment of Mr. S. Madhavan (DIN 06451889) as Non-Executive Independent Director of the Company for a period of five years, effective November 15, 2026
    4 for0 against

Mutual fund votes, meeting of 16 Nov 2025, 9 fund houses

  • Appointment of Mr. Shashank Srowthy (DIN 11317956) as an Executive Director of the Company for a period of five years, effective October 1, 2025, liable to retire by rotation.
    9 for0 against
6 earlier meetings

Mutual fund votes, meeting of 29 Aug 2025, 8 fund houses

  • To receive, consider and adopt the Audited Balance Sheet as at March 31, 2025 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereonMoreLess
    8 for0 against
  • To confirm payment of interim dividend and to declare final dividend for the Financial Year ended March 31, 2025
    8 for0 against
  • To appoint a director in place of Ms. Seema Sambasivan, Non-Executive Director, who retires by rotation and being eligible, offers herself for re-appointment
    8 for0 against
  • To appoint M/s. Dholakia & Associates, Practicing Company Secretaries, as secretarial auditors for a period of five years effective April 1, 2025
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund
    • Bandhan Mutual Fund, Motilal Oswal Mutual FundNo issues on merit of the proposed Secretarial Auditors. Non-Compliant with Regulation 36(5) of SEBI LODR, 2015: Proposed audit fee payable to Secretarial Auditors not disclosed in the Notice
    • Nippon India Mutual FundNon-Compliant with Regulation 36(5) of SEBI LODR, 2015: Proposed audit fee payable to Secretarial Auditors not disclosed in the Notice.
    5 for3 against
  • Ratification of remuneration payable to the Cost Auditor for the Financial Year 2025-26
    8 for0 against

Mutual fund votes, meeting of 9 Apr 2025, 11 fund houses

  • Appointment of Mr. Sharad Tyagi (DIN 00371842) as a Non-Executive Independent Director of Company for a term of five years effective April 1, 2025, not liable to retire by rotation
    Against Groww Mutual Fund
    • Groww Mutual FundNo concern on the merit of proposed appointee. Non-Compliant with SEBI LODR & Companies Act, 2013: Terms and Conditions of appointment of proposed appointees not disclosed on the website of the Company.
    10 for1 against
  • Appointment of Ms. Krishna Sarma (DIN 00016115) as a Non-Executive independent Director of the Company, for a term of five years effective April 1, 2025, not liable to retire by rotation
    Against Groww Mutual Fund
    • Groww Mutual FundNo concern on the merit of proposed appointee. Non-Compliant with SEBI LODR & Companies Act, 2013: Terms and Conditions of appointment of proposed appointees not disclosed on the website of the Company.
    10 for1 against

Mutual fund votes, meeting of 5 Dec 2024, 11 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Balance Sheet as at June 30, 2024 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereon.MoreLess
    11 for0 against
  • To confirm payment of interim dividend and to declare Final Dividend for the Financial Year ended June 30, 2024.
    11 for0 against
  • To appoint a Director in place of Mr. Lokesh Chandak, Executive Director, who retires by rotation and being eligible, offers himself for re- appointment.
    11 for0 against
  • Ratification of remuneration payable to the Cost Auditor for the Financial Year 2024-25.
    10 for0 against
1 proposal not matched to one resolution
  • Approve remuneration of Rs. 500,000 to be paid to Joshi Apte & Associates as cost auditors for FY25
    1 for0 against

Mutual fund votes, meeting of 30 Nov 2023, 10 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Balance Sheet as at June 30, 2023 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereon.MoreLess
    10 for0 against
  • To confirm payment of interim dividend and to declare Final Dividend for the Financial Year ended June 30, 2023.
    10 for0 against
  • To appoint a Director in place of Mr. Aalok Agrawal, Non-Executive Director {DIN 08468145), who retires by rotation and being eligible, offers himself for re- appointment.
    Against SBI Mutual Fund
    • SBI Mutual FundAalok Agrawal, 47, is Senior Vice-President & General Manager, Consumer Healthcare, Asia, Middle-East, Africa, P&G. He has been on the board of the company since 1 June 2019. We observe that there are 7 BODs out of which 3 are classified as IDs. Further, we note that there is 1 ID who are long tenured. Hence, the effective independence of the board at SBI MF framework is assessed at 29%. SBIMF’s internal proxy voting guidelines do not allow us to vote in favor of promoter directors’ or promoter director representatives’ re-appointment if the board is not 50% independent both in number and spirit irrespective of the chairman of the board being an independent director. This is why we do not support the resolution.
    9 for1 against
  • Ratification of remuneration payable to the Cost Auditor for the Financial Year 2023-24
    9 for0 against
1 proposal not matched to one resolution
  • Approve remuneration of Rs. 280,000 to be paid to Joshi Apte & Associates as cost auditors for FY24
    1 for0 against

Mutual fund votes, meeting of 10 May 2023, 8 fund houses

  • Appointment of Mr. Lokesh Chandak (DIN 10083315) as an Executive Director of the Company for a period of five years, effective April 1, 2023, liable to retire by rotation.
    8 for0 against
  • Appointment of Ms. Seema Sambasivan (DIN 10085866) as a Non-Executive Director of the Company, effective April 1, 2023, liable to retire by rotation.
    8 for0 against

Mutual fund votes, meeting of 22 Mar 2023, 6 fund houses

  • RE-APPOINTMENT OF MR. MILIND THATTE (DIN 08092990) AS THEnMANAGING DIRECTOR OF THE COMPANY FOR A PERIOD OF FIVE YEARS EFFECTIVE APRIL 1, 2023
    6 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Dec 2025.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.